The screening mammography paradox: better when found, perhaps better not to find
- PMID: 18506172
- PMCID: PMC2410106
- DOI: 10.1038/sj.bjc.6604349
The screening mammography paradox: better when found, perhaps better not to find
Comment on
-
Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?Br J Cancer. 2008 Jun 3;98(11):1741-4. doi: 10.1038/sj.bjc.6604368. Epub 2008 May 27. Br J Cancer. 2008. PMID: 18506175 Free PMC article.
References
-
- Bazell R (1998) Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer. New York: Random House
-
- Berry DA, Cirrincione C, Henderson IC, Citron ML, Budman DR, Goldstein LJ, Martino S, Perez EA, Muss HB, Norton L, Hudis C, Winer EP (2006a) Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA 295: 1658–1667, Erratum in: JAMA 295: 2356, doi: 10.1001/jama.295.14.1658 - PMC - PubMed
-
- Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JDF, Feuer EJ, Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353: 1784–1792 - PubMed
-
- Berry DA, Inoue L, Shen Y, Venier J, Cohen D, Bondy M, Theriault R, Munsell MF (2006b) Modeling the impact of treatment and screening on US breast cancer mortality: a Bayesian approach. J Natl Cancer Inst Monogr 36: 30–36 - PubMed
-
- Fryback DG, Stout NK, Rosenberg MA, Trentham-Dietz A, Kuruchittham V, Remington PL (2006) The wisconsin breast cancer epidemiology simulation model. J Natl Cancer Inst Monogr 36: 37–47 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical